SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:
“Save the date for our upcoming live session: ‘Overview and clarification of the current HR+ HER2- EBC treatment landscape’.
Topics:
- De-escalation and Escalation of Surgery, Radiotherapy, and Adjuvant Treatment of Breast Cancer.
- Enhancing and Personalising Adjuvant Endocrine Therapy – Current perspectives and future directions.
Wednesday, 27 November – 18:00 CET
Register here.
This webinar is supported by an unrestricted educational grant from Eli Lilly.”
For more information about the event, visit oncodaily.com.